Alexion Pharmaceuticals (NASDAQ:ALXN) posted its quarterly earnings results on Thursday, The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.27, AnalystRatings.NET reports. The company had revenue of $566.60 million for the quarter, compared to the consensus estimate of $560.22 million. Alexion Pharmaceuticals, Inc.(NASDAQ:ALXN) shares after opening at $155.97 moved to $156.98 on last trade day and at the end of the day closed at $152.23. Company price to sales ratio in past twelve months was calculated as 19.41 and price to cash ratio as 19.88. Alexion Pharmaceuticals, Inc.(NASDAQ:ALXN) showed a positive weekly performance of 4.68%.
Tri Quint Semiconductor (NASDAQ:TQNT) was upgraded by Northland Securities from a “market perform” rating to an “outperform” rating in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm currently has a $17.50 target price on the stock, up from their previous target price of $9.00. Northland Securities’ target price would suggest a potential upside of 31.78% from the stock’s previous close. TriQuint Semiconductor (NASDAQ:TQNT) shares fell -0.38% in last trading session and ended the day on $13.28. TQNT return on equity ratio is recorded as -4.30% and its return on assets is -3.70%.TriQuint Semiconductor (NASDAQ:TQNT) yearly performance is 166.13%.
Potash Corp. Saskatchewan (USA)(NYSE:POT) company announced earlier this month that its long-time CEO Bill Doyle would retire in June this year. But the question on the mind of many investors is whether the incoming CEO will be able to turnaround the company and create value for shareholders. Potash Corp. Saskatchewan (USA)(NYSE:POT) shares moved down -1.29% in last trading session and was closed at $35.14, while trading in range of $ 34.97 – 35.54. Potash Corp. Saskatchewan (USA)(NYSE:POT) year to date (YTD) performance is 8.86 reported a first-quarter profit of $665.5 million, or $1.82 a share, up from $490.1 million, or $1.48
Aetna Inc (NYSE:AET) a share, a year earlier. Excluding items such as integration-related costs, per-share operating earnings rose to $1.98 from $1.56.Operating revenue, which excludes net realized capital gains and losses, grew 47% to $13.97 billion, aided by the addition of Coventry. Analysts polled by Thomson Reuters forecast operating earnings of $1.55 a share on revenue of $13.72 billion. Aetna’s total medical benefit ratio, or the amount of premiums used to pay patient medical costs, was 80.4% in the quarter, compared with 81.9% a year earlier. Aetna Inc (NYSE:AET) weekly performance is -3.80%. On last trading day company shares ended up $68.91. Aetna Inc (NYSE:AET) distance from 50-day simple moving average (SMA50) is -3.97%. Analysts mean target price for the company is $80.78.